Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 4;387(5):468-470.
doi: 10.1056/NEJMc2207519. Epub 2022 Jul 20.

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

Emi Takashita  1 , Seiya Yamayoshi  2 , Viviana Simon  3 , Harm van Bakel  3 , Emilia M Sordillo  3 , Andrew Pekosz  4 , Shuetsu Fukushi  1 , Tadaki Suzuki  1 , Ken Maeda  1 , Peter Halfmann  5 , Yuko Sakai-Tagawa  2 , Mutsumi Ito  2 , Shinji Watanabe  1 , Masaki Imai  2 , Hideki Hasegawa  1 , Yoshihiro Kawaoka  6
Affiliations

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

Emi Takashita et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

References

    1. World Health Organization. Weekly epidemiological update on COVID-19. June 1, 2022. (https://www.who.int/publications/m/item/weekly-epidemiological-update-on...).
    1. CoVariants. Overview of variants/mutations. June 3, 2022. (https://covariants.org/per-variant).
    1. Bruel T, Hadjadj J, Maes P, et al. Serum neutralization of SARS-CoV-2 omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies. Nat Med 2022;28:1297-1302. - PubMed
    1. Iketani S, Liu L, Guo Y, et al. Antibody evasion properties of SARS-CoV-2 omicron sublineages. Nature 2022;604:553-556. - PMC - PubMed
    1. Takashita E, Kinoshita N, Yamayoshi S, et al. Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA.2. N Engl J Med 2022;386:1475-1477. - PMC - PubMed

MeSH terms

Supplementary concepts